Statin Treatment as a Targeted Therapy for APC-Mutated Colorectal Cancer

Statin Treatment as a Targeted Therapy for APC-Mutated Colorectal Cancer

BackgroundMutations in the tumor suppressor gene Adenomatous Polyposis Coli (APC) are found in 80% of sporadic colorectal cancer (CRC) tumors and are also responsible for the inherited form of CRC, Familial adenomatous polyposis (FAP).MethodsTo identify novel therapeutic strategies for the treatment...

Full description

Bibliographic Details
Main Authors: Hannah Shailes, Wai Yiu Tse, Marta O. Freitas, Andrew Silver, Sarah A. Martin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
colorectal (colon) cancer
APC
synthetic lethality
personalized medicine
statin (HMG-CoA reductase inhibitor)
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.880552/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.880552/full

Similar Items